The sensitivity and specificity of markers for event times

Biostatistics

Volumn 7, Issue 2, 2006, Pages 182-197

  Cai, Tianxi ^a   Pepe, Margaret Sullivan ^b   Zheng, Yingye ^b   Lumley, Thomas ^c   Jenny, Nancy Swords ^d  

^a HARVARD UNIVERSITY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarker; Classification accuracy; Time dependent discriminatory measure; Transformation models

Indexed keywords

BIOLOGICAL MARKER;

AGED; ARTICLE; BIOMETRY; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MALE; METHODOLOGY; RISK FACTOR; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TIME;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOMETRY; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33645562937     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxi047     Document Type: Article

References (37)

1. BALASUBRAMANIAN, R. AND LAGAKOS, S. (2001). Estimation of the timing of perinatal transmission of HIV. Biometrics 57, 1048-1058.
2. BEGG, C. AND GREENES, R. (1983). Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 39, 207-215.
3. CAI, T. AND PEPE, M. S. (2002). Semiparametric receiver operating characteristic analysis to evaluate biomarkers for disease. Journal of the American Statistical Association 97, 1099-1107.
4. CAI, T., PEPE, M. S., LUMLEY, T., ZHENG, Y. AND JENNEY, N. S. (2003). The sensitivity and specificity of markers for event times. UW Biostatistics Working Paper Series.
5. CAI, T., WEI, L. J. AND WILCOX, M. (2000). Semi-parametric regression analysis for clustered failure time data. Biometrika 87, 867-878.
6. CARNEY, P., MIGLIORETTI, D., YANKASKAS, B., KERLIKOWSKE, K., ROSENBERG, R. AND RUTTER, C. (2003). Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening. Mammography 138, 168-175.
7. CHENG, S. C., WEI, L. J. AND YING, Z. (1995). Analysis of transformation models with censored data. Biometrika 82, 835-845.
8. CHENG, S. C., WEI, L. J. AND YING, Z. (1997). Prediction of survival probabilities with semi-parametric transformation models. Journal of the American Statistical Association 92, 227-235.
9. DABROWSKA, D. AND DOKSUM, K. (1988a). Estimation and testing in a two-sample generalized odds-rate model. Journal of the American Statistical Association 83, 744-749.
10. DABROWSKA, D. AND DOKSUM, K. (1988b). Partial likelihood in transformation models with censored data. Scandinavian Journal of Statistics 15, 1-23.
11. DE GRUTTOLA, V. AND TU, X. M. (1994). Modelling progression of Cd4-lymphocyte count and its relationship to survival time. Biometrics 50, 1003-1014.
12. ETZIONI, R., PEPE, M. S., LONGTON, G., HU, C. AND GOODMAN, G. (1999). Incorporating the time dimension in receiver operating characteristic curves: a case study of prostate cancer. Medical. Decision Making 19, 242-251.
13. FAUCETT, C. L. AND THOMAS, D. C. (1996). Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. Statistics in Medicine 15, 1663-1685.
14. FLEMING, T. R. AND HARRINGTON, D. P. (1991). Counting Processes and Survival Analysis. New York: Wiley.
15. FRIED, L. P., BORHANI, N., ENRIGHT, P., FURBERG, C., GARDIN, J., KRONMAL, R., KULLER, L., MANOLIO, T., MITTELMARK, M., NEWMAN, A. et al. (1991). The cardiovascular health study: design and rationale. Annals of Epidemiology 1, 263-276.
16. GRUNDY, S., BALADY, G., CRIQUI, M., FLETCHER, G., GREENLAND, P., HIRATZKA, L., HOUSTON-MILLER, N., KRIS-ETHERTON, P., KRUMHOLZ, H., LAROSA, J. et al. (1998). Primary prevention of coronary heart disease: guidance from Framingham - a statement for healthcare professionals from the AHA Task Force on risk reduction. Circulation 97, 1876-1887.
17. GRUNDY, S., D'AGOSTINO, R., MOSCA, L., BURKE, G., WILSON, P., RADER, D., CLEEMAN, J., ROCCELLA, E., CUTLER, J. AND FRIEDMAN, L. (2001). Cardiovascular risk assessment based on US cohort studies - findings from a National Heart, Lung, and Blood Institute Workshop. Circulation 104, 491-496.
18. HEAGERTY, P. J., LUMLEY, T. AND PEPE, M. S. (2000). Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56, 337-344.
19. HENDERSON, R., DIGGLE, P. AND DOBSON, A. (2000). Joint modelling of longitudinal measurements and event time data. Biostatistics 1, 465-480.
20. HENDERSON, R., DIGGLE, P. AND DOBSON, A. (2002). Identification and efficacy of longitudinal markers for survival. Biostatistics 3, 33-50.
21. HOGAN, J. W. AND LAIRD, N. M. (1997). Model-based approaches to analysing incomplete longitudinal and failure time data. Statistics in Medicine 16, 259-272.
22. KALBFLEISCH, J. AND PRENTICE, R. (2002). The Statistical Analysis of Failure Time Data. New York: John Wiley.
23. LEISENRING, W., PEPE, M. S. AND LONGTON, G. L. (1997). A marginal regression modelling framework for evaluating medical diagnostic tests. Statistics in Medicine 16, 1263-1281.
24. PARZEN, M. I., WEI, L. J. AND YING, Z. (1994). A resampling method based on pivotal estimating functions. Biometrika 81, 341-350.
25. PAWITAN, Y. AND SELF, S. (1993). Modeling disease marker processes in AIDS. Journal of the American Statistical Association 88, 719-726.
26. PEPE, M. S. (2003). The Statistical Evaluation of Medical Tests for Classification and Prediction. New York: Oxford University Press.
27. PEPE, M. S., ETZIONI, R., FENG, Z. D., POTTER, J., THOMPSON, M., THORNQUIST, M., WINGET, M. AND YASUI, Y. (2001). Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute 93, 1054-1061.
28. PEPE, M. S. AND MORI, M. (1993). Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Statistics in Medicine 12, 737-751.
29. ROBINS, J., ROTNITZKY, A. AND ZHAO, L. P. (1995). Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. Journal of the American Statistical Association 90, 106-121.
30. SCHARFSTEIN, D. O., TSIATIS, A. A. AND GILBERT, P. (1998). Semi-parametric efficient estimation in the generalized odds-rate class of regression models for right-censored time to event data. Lifetime Data Analysis 4, 355-391.
31. SERFLING, R. J. (1980). Approximation Theorems of Mathematical Statistics. New York: Wiley.
32. SKATES, S. J., PAULER, D. K. AND JACOBS, I. J. (2001). Screening based on the risk of cancer calculation from bayesian hierarchical change-point models of longitudinal markers. Journal of the American Statistical Association 96, 429-439.
33. TSIATIS, A. A., DEGRUTTOLA, V. AND WULFSOHN, M. S. (1995). Modeling the relationship of survival to longitudinal data measured with error. Applications to survival and Cd4 counts in patients with AIDS. Journal of the American Statistical Association 90, 27-37.
34. VAN'T VEER, L., DAI, H., VAN DE VIJVER, M., HE, Y., HART, A., MAO, M., PETERSE, H., VAN DER KOOY, K., MARTON, M. AND WITTEVEEN, A. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-535.
35. WANG, Y. AND TAYLOR, J. M. G. (2001). Joint modelling longitudinal and event time data with application to acquired immunodeficiency syndrome. Journal of the American Statistical Association 96, 895-905.
36. WILSON, P., D'AGOSTINO, R., LEVY, D., BELANGER, A., SILBERSHATZ, H. AND KANNEL, W. (1998). Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837-1847.
37. WULFSOHN, M. S. AND TSIATIS, A. A. (1997). A joint model for survival and longitudinal data measured with error. Biometrics 53, 330-339.